ABCG2 and colorectal cancer: Mutual regulation has also been confirmed in other studies, indicating that increased expression of both ABCG2 and EGFR (metastatic marker) is positively correlated with resistance to anoikis [71] and metastatic potential [72] in the colorectal cancer cell population.